vs
Side-by-side financial comparison of BIOMERICA INC (BMRA) and Insight Molecular Diagnostics Inc. (IMDX). Click either name above to swap in a different company.
BIOMERICA INC is the larger business by last-quarter revenue ($1.2M vs $1.1M, roughly 1.1× Insight Molecular Diagnostics Inc.). BIOMERICA INC runs the higher net margin — -109.1% vs -2015.4%, a 1906.3% gap on every dollar of revenue. On growth, Insight Molecular Diagnostics Inc. posted the faster year-over-year revenue change (-23.4% vs -26.0%). Over the past eight quarters, Insight Molecular Diagnostics Inc.'s revenue compounded faster (154.4% CAGR vs 9.1%).
Biomerica Inc. is a global medical technology company that develops, manufactures and markets diagnostic test kits and related medical products. Its portfolio covers gastrointestinal conditions, infectious diseases, food intolerances and point-of-care testing solutions, serving clinical labs, healthcare providers and retail healthcare segments across North America, Europe and Asia.
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
BMRA vs IMDX — Head-to-Head
Income Statement — Q2 2026 vs Q4 2025
| Metric | | |
|---|---|---|
| Revenue | $1.2M | $1.1M |
| Net Profit | $-1.3M | $-23.0M |
| Gross Margin | 4.2% | 42.5% |
| Operating Margin | -113.5% | -2057.5% |
| Net Margin | -109.1% | -2015.4% |
| Revenue YoY | -26.0% | -23.4% |
| Net Profit YoY | -38.9% | 31.5% |
| EPS (diluted) | $-0.45 | $-0.75 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.2M | $1.1M | ||
| Q3 25 | $1.4M | $260.0K | ||
| Q2 25 | $749.0K | $518.0K | ||
| Q1 25 | $1.1M | $2.1M | ||
| Q4 24 | $1.6M | $1.5M | ||
| Q3 24 | $1.8M | $115.0K | ||
| Q2 24 | $1.1M | $104.0K | ||
| Q1 24 | $1.0M | $176.0K |
| Q4 25 | $-1.3M | $-23.0M | ||
| Q3 25 | $2.0K | $-10.9M | ||
| Q2 25 | $-1.5M | $-9.7M | ||
| Q1 25 | $-1.2M | $-6.7M | ||
| Q4 24 | $-950.0K | $-33.5M | ||
| Q3 24 | $-1.3M | $-13.5M | ||
| Q2 24 | $-1.4M | $-4.5M | ||
| Q1 24 | $-1.9M | $-9.1M |
| Q4 25 | 4.2% | 42.5% | ||
| Q3 25 | 30.7% | 53.5% | ||
| Q2 25 | -33.0% | 67.6% | ||
| Q1 25 | 1.7% | 62.0% | ||
| Q4 24 | 26.7% | 40.0% | ||
| Q3 24 | 16.0% | 43.5% | ||
| Q2 24 | 2.1% | 48.1% | ||
| Q1 24 | -14.7% | 25.6% |
| Q4 25 | -113.5% | -2057.5% | ||
| Q3 25 | -81.0% | -4249.2% | ||
| Q2 25 | -209.1% | -1900.0% | ||
| Q1 25 | -108.1% | -318.0% | ||
| Q4 24 | -60.7% | -2262.9% | ||
| Q3 24 | -75.7% | -11752.2% | ||
| Q2 24 | -136.6% | -4453.8% | ||
| Q1 24 | -196.7% | -5265.3% |
| Q4 25 | -109.1% | -2015.4% | ||
| Q3 25 | 0.1% | -4174.6% | ||
| Q2 25 | -206.1% | -1880.7% | ||
| Q1 25 | -103.9% | -312.0% | ||
| Q4 24 | -58.1% | -2255.1% | ||
| Q3 24 | -72.8% | -11733.0% | ||
| Q2 24 | -127.1% | -4355.8% | ||
| Q1 24 | -188.6% | -5186.9% |
| Q4 25 | $-0.45 | $-0.75 | ||
| Q3 25 | $0.00 | $-0.34 | ||
| Q2 25 | $-0.99 | $-0.30 | ||
| Q1 25 | $-0.48 | $-0.26 | ||
| Q4 24 | $-0.06 | $-2.19 | ||
| Q3 24 | $-0.63 | $-0.98 | ||
| Q2 24 | $-2.57 | $-0.36 | ||
| Q1 24 | $-0.11 | $-1.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.5M | $11.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $4.4M | $-31.5M |
| Total Assets | $6.0M | $25.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.5M | $11.6M | ||
| Q3 25 | $3.1M | $18.7M | ||
| Q2 25 | $3.1M | $24.3M | ||
| Q1 25 | $3.1M | $31.0M | ||
| Q4 24 | $2.4M | $8.6M | ||
| Q3 24 | $2.8M | $3.4M | ||
| Q2 24 | $4.2M | $9.3M | ||
| Q1 24 | $5.3M | $5.6M |
| Q4 25 | $4.4M | $-31.5M | ||
| Q3 25 | $5.2M | $-9.2M | ||
| Q2 25 | $4.1M | $1.1M | ||
| Q1 25 | $5.5M | $10.2M | ||
| Q4 24 | $5.1M | $-12.3M | ||
| Q3 24 | $5.3M | $9.7M | ||
| Q2 24 | $6.6M | $22.7M | ||
| Q1 24 | $7.8M | $11.6M |
| Q4 25 | $6.0M | $25.8M | ||
| Q3 25 | $6.9M | $43.9M | ||
| Q2 25 | $5.9M | $50.5M | ||
| Q1 25 | $7.4M | $60.4M | ||
| Q4 24 | $7.3M | $35.1M | ||
| Q3 24 | $7.9M | $70.2M | ||
| Q2 24 | $9.3M | $74.7M | ||
| Q1 24 | $10.3M | $71.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-991.0K | $-5.5M |
| Free Cash FlowOCF − Capex | — | $-7.0M |
| FCF MarginFCF / Revenue | — | -616.7% |
| Capex IntensityCapex / Revenue | — | 129.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-25.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-991.0K | $-5.5M | ||
| Q3 25 | $-268.0K | $-4.5M | ||
| Q2 25 | $-661.0K | $-6.3M | ||
| Q1 25 | $-1.0M | $-5.9M | ||
| Q4 24 | $-791.0K | $-5.4M | ||
| Q3 24 | $-1.3M | $-5.5M | ||
| Q2 24 | $-1.0M | $-6.0M | ||
| Q1 24 | $-1.8M | $-3.8M |
| Q4 25 | — | $-7.0M | ||
| Q3 25 | — | $-5.6M | ||
| Q2 25 | — | $-6.6M | ||
| Q1 25 | — | $-6.2M | ||
| Q4 24 | — | $-5.6M | ||
| Q3 24 | — | $-5.6M | ||
| Q2 24 | $-1.1M | $-6.2M | ||
| Q1 24 | — | $-3.9M |
| Q4 25 | — | -616.7% | ||
| Q3 25 | — | -2135.4% | ||
| Q2 25 | — | -1279.5% | ||
| Q1 25 | — | -288.4% | ||
| Q4 24 | — | -374.5% | ||
| Q3 24 | — | -4884.3% | ||
| Q2 24 | -95.5% | -5931.7% | ||
| Q1 24 | — | -2189.8% |
| Q4 25 | — | 129.9% | ||
| Q3 25 | — | 403.8% | ||
| Q2 25 | — | 67.4% | ||
| Q1 25 | — | 14.4% | ||
| Q4 24 | — | 14.4% | ||
| Q3 24 | — | 75.7% | ||
| Q2 24 | 2.1% | 183.7% | ||
| Q1 24 | 0.0% | 13.6% |
| Q4 25 | — | — | ||
| Q3 25 | -134.00× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
